EW Feb 2025 105.000 call
| Previous close | 3.0000 |
| Open | 3.0000 |
| Bid | 0.0000 |
| Ask | 0.9500 |
| Strike | 105.00 |
| Expiry date | 2025-02-21 |
| Day's range | 3.0000 - 3.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
ZacksEarnings Preview: DexCom (DXCM) Q3 Earnings Expected to Decline
DexCom (DXCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireEdwards Lifesciences to Host Earnings Conference Call on October 24, 2024
IRVINE, Calif., October 17, 2024--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2024 after the market closes on Thursday, October 24, 2024, and will host a conference call at 5:30 p.m. ET that day to discuss those results.
Insider MonkeyArtisan Mid Cap Fund Sold Edwards Lifesciences Corporation (EW) as it Failed to Meet Growth Expectations
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return of 2.38%, and Institutional Class fund APHMX returned 2.40%, compared […]
